The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)German Foreign Ministry Spokesperson: Berlin will hold the Weimar Triangle Foreign Ministers' Meeting on Thursday, and representatives from Italy, Spain, Britain and the European Union will also attend.Blonde Technology: Shareholders holding more than 5% of the shares plan to transfer 2% of the shares internally. Blonde Technology announced that as of the announcement date, Ms. Xiong Haitao, a shareholder, holds 122 million shares of the company, accounting for 4.64% of the company's total share capital; Ms. Xiong Haitao and her concerted actions hold a total of 216 million shares, accounting for 8.2% of the total share capital. Ms. Xiong Haitao plans to sign an agreement with Warburg Wanying Private Equity Fund to increase it as a concerted action, and plans to transfer no more than 52.73 million shares to it through block trading, that is, no more than 2% of the total share capital. After the transfer is completed, Huabao Wanying will entrust Ms. Xiong Haitao with the right to vote on the shares. This internal transfer does not involve market reduction, and the shareholding ratio remains unchanged, which does not affect the company's control.
The minimum acceptable price of the two-year national debt issued by the Ministry of Finance in Hong Kong is 100.62 yuan. The minimum acceptable price of the five-year national debt issued by the Ministry of Finance in Hong Kong is 102.41 yuan.Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was investigated. Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was suspected of serious violation of the law and is currently under disciplinary review and supervision investigation by the Supervision Committee of Guangyuan Municipal Commission for Discipline Inspection.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
It is reported that the Bank of Japan thinks that it is no harm to raise interest rates later, but it does not rule out taking action in December. On December 11th, according to informed sources, officials of the Bank of Japan believe that it is not costly to raise interest rates later, and they are still open to taking action next week, depending on data and market trends. The authorities believe that even if the Bank of Japan decides to wait until January or later, it will not pay a huge price, because there are signs that there is little risk that inflation may exceed the target. They also said that if the December meeting proposed to raise interest rates, some officials would not object. According to people familiar with the matter, officials think it is only a matter of time to raise interest rates again, because the economy and inflation are in line with their forecasts. Before announcing the policy decision on December 19, officials will carefully evaluate the data and financial markets before making a final decision.Song Zhexie, Samsung Semiconductor: I feel the great potential of the semiconductor market in China and I am very willing to grow with China customers. At the Shanghai IC Industry Development Forum 2024 held today, Song Zhe Xie, general manager of Samsung Semiconductor Foundry Greater China, said that the semiconductor industry in China is not only growing in scale, but also improving the development quality of the whole industry from the product upgrading and process evolution of Samsung semiconductor customers. The development of new quality productivity is helping the semiconductor market in China to flourish. In the cooperation with customers in China, I feel the great potential of the semiconductor market in China, and I am very willing to grow with customers in China, and provide diversified solutions to meet the needs of customers in China to enhance the competitiveness of products.In 2024, the e-sports industry grew by 4.6% year-on-year, and the live broadcast revenue of e-sports content accounted for the highest proportion. On December 11th, the 2024 China E-sports Industry Annual Conference was held in Beijing. The 2024 China E-sports Industry Report was officially released at the meeting. According to the report, the actual income of e-sports industry in China in 2024 was 27.568 billion yuan, up 4.6% year-on-year. In the income composition, the live broadcast of e-sports content is still the sector with the highest proportion of income, reaching 80.84%; The income from the competition accounts for 8.75%; E-sports club income is 6.37%, and other income is 4.04%. (The country is a through train)
Strategy guide
12-14
Strategy guide 12-14